LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson’s disease: a review
Abstract Parkinson’s disease (PD) is the most common movement disorder and manifests as resting tremor, rigidity, bradykinesia, and postural instability. Pathologically, PD is characterized by selective loss of dopaminergic neurons in the substantia nigra and the formation of intracellular inclusion...
Main Authors: | Meng-Ling Chen, Ruey-Meei Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12929-018-0454-0 |
Similar Items
-
A Conserved Role for LRRK2 and Roco Proteins in the Regulation of Mitochondrial Activity
by: Katharina E. Rosenbusch, et al.
Published: (2021-09-01) -
Structural biology of the LRRK2 GTPase and Kinase domains: Implications for regulation
by: Bernd Karl Gilsbach, et al.
Published: (2014-05-01) -
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism
by: Meng-Ling Chen, et al.
Published: (2022-08-01) -
Functional properties of LRRK2 mutations in Taiwanese Parkinson disease
by: Kuo-Hsuan Chang, et al.
Published: (2017-03-01) -
A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
by: Herschel S Dhekne, et al.
Published: (2018-11-01)